#Japan #Tokyo #CooperVision #Myopia Control #MiSight

CooperVision's Launch of MiSight® 1 Day in Japan

CooperVision has announced the immediate availability of its innovative MiSight® 1 day myopia control contact lenses across Japan, a country where myopia afflicts an estimated 77% of elementary school-aged children. This groundbreaking product marks a significant milestone as it is the first soft contact lens authorized by the Ministry of Health, Labor, and Welfare in Japan specifically for children.

The MiSight® 1 day lenses aim to directly address the growing concern of myopia—a condition that affects nearly one in three children globally and is predicted to escalate to nearly five billion affected individuals by 2050. Myopia is not just a vision correction issue; it impacts daily activities such as learning, sports, and overall quality of life.

Jennifer Lambert, Vice President of Myopia Management and Cornea Care at CooperVision, stated, “This development underscores our commitment to enhancing children’s lives by improving access to effective myopia control solutions.” The launch of MiSight® 1 day embodies an effort to partner with local ophthalmology professionals to ensure that young patients can see clearly while also safeguarding their future vision.

What sets MiSight® 1 day apart is its patented ActivControl® Technology, which combines vision correction with zones designed to create myopia defocus. This unique feature helps slow the progression of myopia. Clinical studies have demonstrated that children wearing MiSight® lenses experienced an average 59% reduction in myopia progression over three years.

The lenses are available in more than 40 countries, and Japan becomes one of the few markets, alongside the United States and China, to offer this specialized product. Currently, children using MiSight® 1 day collectively account for over half a billion hours of wear annually, which equates to millions of opportunities to manage and control myopia effectively.

Debbie Olive, Chief Commercial Officer at CooperVision, emphasized the broader implications of myopia management, stating, “For families facing the challenges associated with myopia, access to proven solutions allows them to navigate those hurdles without feeling isolated in their struggle.” The introduction of MiSight® 1 day is also a part of CooperVision’s wider strategy to enhance its portfolio of myopia control solutions, which includes an extensive range of evidence-based products tailored to meet the diverse needs of children and their families.

In conclusion, CooperVision’s decision to launch the MiSight® 1 day in Japan not only addresses a critical health concern among children but also represents a proactive step towards ensuring healthier futures for generations to come. Parents and guardians in Japan can now access this innovative solution to help manage their children's myopia effectively. With such advancements in eye care, the landscape of pediatric vision management continues to evolve, promising improvements in the quality of life for countless children worldwide.

For more information on CooperVision’s myopia management solutions, you can visit their official website or consult a local eyecare professional to better understand how MiSight® 1 day can support the needs of children experiencing myopia.